abbexa
SARS-CoV-2 Spike Protein RBD (Beta B.1.351 Variant) | abx620004
- SKU:
- abx620004
- Availability:
- Usually shipped in 5 working days
Description
SARS-CoV-2 Spike Protein RBD (Beta B.1.351 Variant). Cat# abx620004. Supplier: abbexa.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Protein Receptor-Binding Domain (RBD) is a recombinant protein expressed in Mammalian cells.
The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the Spike Protein and S2 subunits that is targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion). Antibodies to S protein can prevent viral entry as well as target the virus for further immune action.
The Beta (B.1.351) variant was first identified in South Africa. It contains the K417N, E484K and N501Y mutations in the spike protein's receptor-binding domain.
| Target | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein RBD (Beta B.1.351 Variant) |
| Target Modification | Lys417Asn, Glu484Lys, Asn501Tyr |
| Modification | Mutation |
| Origin | Virus |
| Expression | Recombinant |
| Host | Mammalian cells |
| Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Form | Lyophilized |
| Purity | > 90% (SDS-PAGE) |
| Reconstitution | Reconstitute in ddH2O to a concentration of 1 mg/ml. |
| Storage | Store between -20 °C and -80 °C. Avoid repeated freeze/thaw cycles. |
| NCBI Accession | YP_009724390.1 |
| Molecular Weight | Observed MW: 35 kDa |
| Tag | C-terminal His tag |
| Buffer | Prior to lyophilization: PBS, pH 7.5. |
| Availability | Shipped within 5-10 working days. |
| Note | This product is for research use only. |
Related Products
SARS-CoV-2 S1 Protein RBD (Beta B.1.351 Variant) | abx160085
abbexa
SARS-CoV-2 Spike Protein RBD (B.1.617 Variant) | abx620009
abbexa
SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant) | abx620012
abbexa
SARS-CoV-2 Spike Protein RBD (Alpha B.1.1.7 Variant) | abx620010
abbexa
SARS-CoV-2 Spike Protein RBD (Delta Plus B.1.617.2.1 Variant) | abx620018
abbexa
SARS-CoV-2 Spike B.1.351 Mutation RBD Domain (South African Variant, 100ug) | BSV-COV-PR-74
BioServUK
SARS-CoV-2 S1 Protein RBD (B.1.617 Variant) | abx160088
abbexa
SARS-CoV-2 Spike Protein RBD (Gamma P.1 Variant) | abx620006
abbexa
SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant) Neutralizing Antibody | abx376487
abbexa